Literature DB >> 9422846

Biology of the endothelium.

T F Lüscher1, M Barton.   

Abstract

The endothelium releases factors that control vascular relaxation and contraction, thrombogenesis and fibrinolysis, and platelet activation and inhibition. Maintaining the functional integrity of the endothelium, therefore, is critical for the preservation of blood flow and the prevention of thrombosis. This article reviews the primary endothelium-dependent substances that promote either relaxation (e.g., nitric oxide, prostacyclin) or contraction (e.g., endothelin) of blood vessels, including their physiology, mechanism of effect, and role in endothelial dysfunction. Risk factors for cardiovascular disease, such as hypertension, hypercholesterolemia, diabetes, vascular aging, and estrogen deficiency, are discussed in terms of their contributions to endothelial dysfunction, which may be the initial step in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422846

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  108 in total

Review 1.  Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.

Authors:  R A Archbold; A D Timmis
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

2.  Elasticity changes anti-correlate with NO production for human endothelial cells stimulated with TNF-α.

Authors:  Agnieszka M Szczygiel; Grzegorz Brzezinka; Marta Targosz-Korecka; Stefan Chlopicki; Marek Szymonski
Journal:  Pflugers Arch       Date:  2011-12-13       Impact factor: 3.657

3.  Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging.

Authors:  Amy L Sindler; Bradley S Fleenor; John W Calvert; Kurt D Marshall; Melanie L Zigler; David J Lefer; Douglas R Seals
Journal:  Aging Cell       Date:  2011-03-31       Impact factor: 9.304

4.  The prevalence of endothelial dysfunction in patients with and without coronary artery disease.

Authors:  Stefan Toggweiler; Andreas Schoenenberger; Nadja Urbanek; Paul Erne
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

5.  Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography.

Authors:  Erick Alexanderson; Patricio Cruz; Angélica Vargas; Aloha Meave; Alejandro Ricalde; Jose A Talayero; José Luis Romero-Ibarra; Tovë M Goldson; Olga L Vera-Lastra; Gabriela Medina; Luis Jara; Mary-Carmen Amigo
Journal:  J Nucl Cardiol       Date:  2007-07-02       Impact factor: 5.952

6.  Effects of antihypertensive treatment on endothelial function.

Authors:  Agostino Virdis; Lorenzo Ghiadoni; Stefano Taddei
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

7.  Difference in protective effects of GIP and GLP-1 on endothelial cells according to cyclic adenosine monophosphate response.

Authors:  Dong-Mee Lim; Keun-Young Park; Won-Min Hwang; Ju-Young Kim; Byung-Joon Kim
Journal:  Exp Ther Med       Date:  2017-03-29       Impact factor: 2.447

8.  Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats.

Authors:  S Kagota; A Tamashiro; Y Yamaguchi; R Sugiura; T Kuno; K Nakamura; M Kunitomo
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

Review 9.  Scientific rationale for combination of a calcium channel antagonist and an HMG-CoA reductase inhibitor: a new approach to risk factor management.

Authors:  R Preston Mason
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Histone deacetylase 5 interacts with Krüppel-like factor 2 and inhibits its transcriptional activity in endothelium.

Authors:  Il-Sun Kwon; Weiye Wang; Suowen Xu; Zheng-Gen Jin
Journal:  Cardiovasc Res       Date:  2014-08-05       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.